longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

DNTH

DNTH
103.2803.51%( -3.760 )

LongbridgeAI

Dianthus Therapeutics CEO to join Citi Biopharma Back to School fireside chat

PUBT
Sep 1, 2026 at 12:06 PM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

Dianthus Therapeutics CEO Marino Garcia will participate in investor meetings and fireside chats at three major conferences in September 2026. He is scheduled to join the Wells Fargo Healthcare Conference on Sept. 8, Citi’s Biopharma Back to School Conference on Sept. 9, and the Cantor Global Healthcare Conference on Sept. 10.

  • Dianthus Therapeutics will hold investor meetings at the Wells Fargo 21st Annual Healthcare Conference on Sept. 8, 2026. * CEO Marino Garcia will join a fireside chat at Citi’s 2026 Biopharma Back to School Conference on Sept. 9, 2026 at 4:20 p.m. ET. * Garcia will also participate in a fireside chat at the 2026 Cantor Global Healthcare Conference on Sept. 10, 2026 at 8:35 a.m. ET. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dianthus Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609010800PRIMZONEFULLFEED9818930) on September 01, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

Login to unlock501characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Related Stocks

Dianthus Therapeutics

Dianthus Therapeutics

USDNTH

-3.51%

Citigroup

Citigroup

USC

Wells Fargo

Wells Fargo

USWFC